Prostate cancer (PCa) is the most prevalent cancer in men in the Western world, and its primary treatment involves androgen deprivation therapy (ADT) and blockade of androgen receptor (AR) signaling [1, 2]. The gene discussed is AR; the disease is prostate carcinoma.